{"id":6374,"date":"2012-07-04T06:52:42","date_gmt":"2012-07-04T06:52:42","guid":{"rendered":"https:\/\/2016.csoftintl.com\/?p=6374"},"modified":"2018-08-28T08:20:35","modified_gmt":"2018-08-28T08:20:35","slug":"csoft-helps-chinese-companies-go-global-in-china-daily","status":"publish","type":"post","link":"https:\/\/www.csoftintl.com\/cn\/news-events\/csoft-helps-chinese-companies-go-global-in-china-daily\/","title":{"rendered":"“CSOFT helps Chinese companies go global” \u2013 Article about CSOFT published in China Daily"},"content":{"rendered":"
Such business is expected to generate a quarter of the company’s revenue next year, whereas in the past, revenue was dominated by Fortune 500 clients requiring localization support in China.<\/p>\n Shunee Yee, president and CEO of CSOFT, said Chinese firms are transforming themselves from OEM manufacturers for other brands into “world-class partners”, which has added value to the global supply chain. Yee said this is comparable to China opening a new Silk Road to the West.<\/p>\n Click here to read the full article in China Daily<\/a><\/p>\n <\/p>\n\n CSOFT Health Sciences, leaders in clinical trial localization, provides AI\/ML-enabled medical translation services for all phases of the drug and medical device product lifecycle, from development to post-launch. We also specialize in DCT solutions, linguistic validation, and CTD\/eCTD submissions with the FDA, EMA, and NMPA. Our operations are certified in ISO 17100:2015, ISO 9001:2015, and ISO 13485:2016, ensuring our customized solutions meet the rigorous regulatory requirements of MMA, NDA, CTA, and Medical Device Application submissions. www.csoftintl.com<\/u><\/a><\/p>\n \n <\/div>\n\r\n
<\/a>As a leading global communications company that provides globalization and language solutions for businesses around the world, CSOFT has high expectations for Chinese firms looking to go global.<\/p>\nAbout CSOFT Health Sciences<\/h3>\n